The verification study for improving the intestinal environment: a randomized, double-blind, placebo-controlled, parallel-group trial - The verification study for improving the intestinal environment

ORTHOMEDICO Inc.0 个研究点目标入组 44 人开始时间: 2020年4月1日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•1. Subjects who are undergoing medical treatment or have a medical history of malignant tumor, heart failure, or myocardial infarction 2. Subjects who have a pacemaker or an implantable cardioverter defibrillator (ICD) 3. Currently undergoing treatment for any of the following chronic disease: cardiac arrhythmia, liver disorder, kidney disorder, cerebrovascular disorder, rheumatism, diabetes mellitus, dyslipidemia, hypertension, irritable bowel syndrome (IBS), or any other chronic diseases 4. Subjects who daily take "Foods for Specified Health Uses", "Foods with Functional Claims", yogurt, lactic fermenting beverage, or other functional food/beverage. Particularly taking food/beverage effective in intestine regulating. 5. Subjects who are currently taking medications (including herbal medicines) and supplements 6. Subjects who are allergic to medicines and/or the test food related products 7. Subjects who are pregnant, breast-feeding, and planning to become pregnant 8. Subjects who have been enrolled in other clinical trials within the last three months before the agreement to participate in this trial or plan to enroll in another clinical trial during trial period 9. Subjects who are judged as ineligible to participate in the study by the physician

发起方